Excel.lent defensa de tesi d’ @ezemauro_ok fruit d’una llarga i exitosa col.laboració entre la UTH y @BCVirHep de @liverunitclinic!!! Felicitats als directors i bona feina del tribunal: Santi, Isabel i @SaSi_Lens
The @BCVirHep team actively participating in the international #HBV2022 in Paris, no doubt the best meeting in #HBV!! Great to see again in person our friends in the field and enjoy intense Q&A sessions
Regarding biomarkers guiding stopping #HBV NA therapy ➡️significant amount of data is available but still so many unanswered questions 🧐‼️ @SaSi_Lens at the joint @APASLnews@EASLnews symposium @apasl2022 in Seoul chaired by @ThomasBerg24
👋 Hey my #livertwitter & #LiverPath friends, take a look to a new free platform https://t.co/jKYu7MeELg to learn, share and engage on liver diseases & liver pathology
👨👨👧 Designed by @livercases and endorsed by @AEEHLiver
🧠 1 new challenge every #LiverMonday. Join us!
✨Glad to see our study published in @JHepatology mentioned during #HBV ANRS 2021 workshop https://t.co/s1AF4VkIVL 💪
Still much work to do to increase our understanding about predictors of good outcome after stopping #HBV treatment 🧐 #livertwitter@AEEHLiver@EASLnews
🆕Research Article just out❕
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules
Read it here👉https://t.co/05IjR78yge
@ma5RN@bruixj@MarcoSanduzzi
@ZoeMario2
@BCLC_group@BCVirHep#LiverTwitter
Conferencia magistral de @MeriHuchlab en la Escuela de Investigación del @CIBERehd en @idibaps :
��️ Adult-tissue derived organoid cultures and their biomedical applications
Interesantísima + muy buena discusión con los investigadores junior!